510(k) K202644
K202644 is an FDA 510(k) premarket notification submitted by Sekisui Diagnostics P.E.I., Inc. for the device "Acetaminophen". The FDA issued a decision of Substantially Equivalent on February 18, 2022. The device falls under product code LDP (Colorimetry, Acetaminophen), a Class II device regulated under 21 CFR 862.3030. Sekisui Diagnostics P.E.I., Inc. has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 18, 2022
- Date Received
- September 11, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Colorimetry, Acetaminophen
- Device Class
- Class II
- Regulation Number
- 862.3030
- Review Panel
- TX
- Submission Type